BackgroundCheck.run
Search For

Kevin P Raisch, 66Lithia, FL

Kevin Raisch Phones & Addresses

Lithia, FL   

Gainesville, FL   

Trussville, AL   

1733 Creely Cir, Birmingham, AL 35235    205-8539406   

Rochester, MN   

Fort Collins, CO   

Milwaukee, WI   

2015 NW 89Th Dr, Gainesville, FL 32606   

Social networks

Kevin P Raisch

Linkedin

Work

Company: City college-altamonte springs Apr 2017 to Jun 2017 Position: Adjunct faculty

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Colorado State University 1986 to 1989 Specialities: Microbiology

Skills

Leadership • Microsoft Office • Management • Project Management • Research • Microsoft Excel • Immunology • Molecular and Cellular Biology • Fluorescence Microscopy • Strategic Planning • Microbiology

Industries

Higher Education

Mentions for Kevin P Raisch

Kevin Raisch resumes & CV records

Resumes

Kevin Raisch Photo 16

Instructor

Location:
5908 Hidden Path Cir, Lithia, FL
Industry:
Higher Education
Work:
City College-Altamonte Springs Apr 2017 - Jun 2017
Adjunct Faculty
Keiser University-Clearwater Apr 2017 - Jun 2017
Instructor
Chamberlain College of Nursing Feb 2017 - Apr 2017
Visiting Professor
Keiser University Aug 2016 - Apr 2017
Adjunct Instructor
University of Florida Dec 2011 - Dec 2015
Research Assistant Professor
The University of Alabama at Birmingham Jun 2000 - Dec 2011
Assistant Professor
The University of Alabama at Birmingham Jun 1998 - May 2000
Instructor
Medical College of Wisconsin Dec 1993 - May 1998
Research Scientist
Mayo Clinic Oct 1989 - Nov 1993
Postdoctoral Fellow and Research Associate
Colorado State University Aug 1986 - May 1987
Graduate Teaching Assistant
Iowa State University Aug 1983 - May 1986
Graduate Teaching Assistant
Iowa State University May 1981 - Jul 1983
Microbiology Technician
National Animal Disease Center Aug 1979 - May 1981
Biological Laboratory Aide
Education:
Colorado State University 1986 - 1989
Doctorates, Doctor of Philosophy, Microbiology
Iowa State University 1983 - 1986
Master of Science, Masters, Microbiology
Iowa State University 1976 - 1981
Bachelors, Bachelor of Science, Microbiology
Skills:
Leadership, Microsoft Office, Management, Project Management, Research, Microsoft Excel, Immunology, Molecular and Cellular Biology, Fluorescence Microscopy, Strategic Planning, Microbiology

Publications & IP owners

Us Patents

Human Anti-Epidermal Growth Factor Receptor Single-Chain Antibodies

US Patent:
6699473, Mar 2, 2004
Filed:
Oct 12, 2001
Appl. No.:
09/976118
Inventors:
Kevin Paul Raisch - Birmingham AL
David T. Curiel - Birmingham AL
James Alan Bonner - Vestavia Hills AL
Assignee:
UAB Research Foundation - Birmingham AL
International Classification:
C07K 1628
US Classification:
4241351, 424 111, 424 149, 5303871, 5303873
Abstract:
Human anti-epidermal growth factor receptor (EGFR) single-chain antibodies (scFvs) were isolated from a human IgM phage display library using purified epidermal growth factor receptor as antigen. Two isolates with different amino acid sequences were identified by ELISA as epidermal growth factor receptor-specific. The scFvs bind to the full length epidermal growth factor receptor and the truncated and/or mutated epidermal growth factor receptor on human cells. These anti-EGFR-scFvs are useful as therapeutic and/or diagnostic agents.

Human Anti-Epidermal Growth Factor Receptor Single-Chain Antibodies

US Patent:
7045127, May 16, 2006
Filed:
Nov 6, 2003
Appl. No.:
10/703277
Inventors:
Kevin Paul Raisch - Birmingham AL, US
David T. Curiel - Birmingham AL, US
James Alan Bonner - Vestavia Hills AL, US
Assignee:
The UAB Research Foundation - Birmingham AL
International Classification:
C07K 16/28
A61K 39/395
US Classification:
4241351, 424 111, 424 149, 5303871, 5303873
Abstract:
Human anti-epidermal growth factor receptor (EGFR) single-chain antibodies (scFvs) were isolated from a human IgM phage display library using purified epidermal growth factor receptor as antigen. Two isolates with different amino acid sequences were identified by ELISA as epidermal growth factor receptor-specific. The scFvs bind to the full length epidermal growth factor receptor and the truncated and/or mutated epidermal growth factor receptor on human cells. These anti-EGFR-scFvs are useful as therapeutic and/or diagnostic agents.

Human Anti-Epidermal Growth Factor Receptor Single-Chain Antibodies

US Patent:
2006011, May 25, 2006
Filed:
Dec 23, 2005
Appl. No.:
11/317435
Inventors:
Kevin Raisch - Birmingham AL, US
David Curiel - Birmingham AL, US
James Bonner - Vestavia Hills AL, US
International Classification:
A61K 51/00
A61K 39/395
C07K 16/28
C07K 16/46
US Classification:
424001490, 424143100, 530388220
Abstract:
Human anti-epidermal growth factor receptor (EGFR) single-chain antibodies (scFvs) were isolated from a human IgM phage display library using purified epidermal growth factor receptor as antigen. Two isolates with different amino acid sequences were identified by ELISA as epidermal growth factor receptor-specific. The scFvs bind to the full length epidermal growth factor receptor and the truncated and/or mutated epidermal growth factor receptor on human cells. These anti-EGFR-scFvs are useful as therapeutic and/or diagnostic agents.

Molecular Basis For The Identification Of Chemotherapy Resistance In Human Tumors And The Treatment Thereof

US Patent:
2008013, Jun 5, 2008
Filed:
Nov 16, 2005
Appl. No.:
11/719017
Inventors:
Donald J. Buchsbaum - Alabaster AL, US
Martin R. Johnson - Birmingham AL, US
James A. Bonner - Birmingham AL, US
Kevin P. Raisch - Trussville AL, US
Assignee:
THE UAB RESEARCH FOUNDATION - Birmingham AL
International Classification:
C40B 20/02
G06F 17/00
C12Q 1/68
C40B 40/06
C40B 20/00
US Classification:
506 3, 7071041, 435 6, 506 16, 506 2, 707E17009
Abstract:
Provided are compositions and methods for determining whether a tumor in a subject is sensitive or resistant to a chemotherapeutic agent. Further provided are methods and compositions for identifying a chemotherapeutic agent to which a subject's tumor is resistant or sensitive. Methods and compositions for selecting a chemotherapeutic agent for treating a subject with a tumor are also provided.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.